SEARCH

SEARCH BY CITATION

References

  • 1
    Syrjänen K, Pyrhönen S, Aukee S, Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982; 5: 291296.
  • 2
    Syrjänen S. Papillomavirus infections in the oral cavity. In: Syrjanen K , Gissman L , Koss L (eds). Papillomavirus and Human Disease. Springer Verlag, Berlin 1987; 104137.
  • 3
    Hille J, Margolius K, Markowitz S, Isaacson C. Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. S Afr Med J 1986; 69: 417420.
  • 4
    Mori M, Shimono R, Inoue T, Kuwano H, Sugimachi K, Zhang R. Papillomavirus and esophageal cancer in the Japanese and Chinese. Am J Gastroenterol 1989; 84: 11261127.
  • 5
    Syrjänen K. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721728.
  • 6
    World Health Organisation. Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. World Health Organisation and International Agency for Research on Cancer, Lyons: 2007.
  • 7
    Syrjänen K. HPV and oesophageal carcinoma. In: Campo MS (ed.). Papillomavirus Research: From Natural History to Vaccines and Beyond. Caister Academic Press, Norfolk: 2006; 229253.
  • 8
    Hennekens C, Buring J. Case-control studies. In: Mayrent S (ed.). Epidemiol Med, 1st edn. Little, Brown and Company, Boston, MA/Toronto 1987; 132152.
  • 9
    Dean AG, Arner TG, Sunki GG et al. Epi Info 3.5.3 ed. Centres for Disease Control and Prevention (CDC), Atlanta, GA 2011.
  • 10
    Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer, Lyons, France 2010.
  • 11
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 28932917.
  • 12
    Mudan S, Kang J. Epidemiology and clinical presentation in esophageal cancer. In: Rankin S (ed.). Carcinoma of the Esophagus. Cambridge University Press, New York 2008; 110.
  • 13
    Holmes R, Vaughn T. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2006; 17: 29.
  • 14
    Curado M, Edwards B, Shin H et al. Cancer Incidence in Five Continents. IARC, Lyon, France 2007.
  • 15
    Castellsagué X, Muñoz N, De Stefani E et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 1999; 82: 657664.
  • 16
    Bosetti C, La Vecchia C, Talamini R et al. Food groups and risk of squamous cell esophageal cancer in northern Italy. J. Cancer 2000; 87: 289294.
  • 17
    Ward E. Occupational diseases and injury – esophageal cancer. In: Levy B , Wagner G , Rest K , Weeks J (eds). Preventing Occupational Disease and Injury, 2nd edn. American Public Health Association, Washington, DC 2005; 195196.
  • 18
    Islami F, Boffetta P, Ren J-S, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk – a systematic review. Int J Cancer 2009; 125: 491524.
  • 19
    Wu D-C, Wu IC, Lee J-M et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 2005; 100: 588593.
  • 20
    Chang F, Syrjänen S, Wang L, Syrjänen K. Infectious agents in the etiology of esophageal cancer. Gastroenterology 1992; 103: 13351348.
  • 21
    Del V, White M, Enam S et al. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 2005; 103: 516527.
  • 22
    Selgrad M, Malfertheiner P, Fini L, Goel A, Boland CR, Ricciardiello L. The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol 2008; 216: 378388.
  • 23
    International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyons, France 1995.
  • 24
    zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology 2009; 384: 260265.
  • 25
    Garland S, Hernandez-Avila M, Wheeler C et al. Quadrivalent vaccine against the human papillomavirus to prevent cervical, vulvar and vaginal disease. N Engl J Med 2007; 356: 19281943.
  • 26
    Garrote LF, Herrero R, Reyes RMO et al. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer 2001; 85: 4654.
  • 27
    Kreimer Aimee R, Alberg Anthony J, Daniel R et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686698.
  • 28
    Smith E, Johnson S, Cripe T, Pignatari S, Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol 1991; 100: 478483.
  • 29
    Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503517.
  • 30
    Chang F, Syrjanen S, Shen Q, Wang L, Wang D, Syrjänen K. Human papillomavirus (HPV) involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992; 27: 553563.
  • 31
    Choo K, Pan C, Han S. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987; 161: 259261.
  • 32
    Jeon S, Allen-Hoffman B, Lambert P. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69: 29892997.
  • 33
    Pagluisi S, Garland S. International standard reagents for HPV detection. Dis Markers 2007; 23: 283296.
  • 34
    Quint WGV, Pagliusi SR, Lelie N, de Villiers E-M, Wheeler CM, the World Health Organization Human Papillomavirus DNA International Collaborative Study Group. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 2006; 44: 571579.
  • 35
    Campo M. Papillomas and cancer in cattle. Cancer Surv 1987; 6: 3954.
  • 36
    Jarrett W. Environmental carcinogens and papillomaviruses in the pathogenesis of cancer. Proc R Soc Lond B Biol Sci 1987; 231: 111.
  • 37
    Syrjänen KJ. HPV infections and lung cancer. J Clin Pathol 2002; 55: 885891.
  • 38
    Anderson R, Scobie L, O'Neil B, Grindlay G, Campo M. Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. Vet J 1997; 154: 6978.
  • 39
    zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999; 111: 581587.
  • 40
    Garland S, Steben M, Sings H et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. J Infect Dis 2009; 119: 805814.
  • 41
    Batra P, Hebert R, Haines G, Holinger L. Recurrent respiratory papillomatosis with esophageal involvement. Int J Pediatr Otolaryngol 2001; 58: 233238.
  • 42
    Chistiakova V, Lablonskiĭ S, Kovshenkova I. Two cases of generalized papillomatosis of the upper respiratory tract and esophagus in children. Vestn Otorinolaringol 1998; 5: 5657.
  • 43
    Lagergren J, Wang Z, Bergstrom R, Dillner J, Nyren O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst 1999; 91: 156162.
  • 44
    Van Doornum GJJ, Korse CM, Buning-Kager JCGM et al. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer 2002; 88: 10951100.
  • 45
    Dillner J, Knekt P, Schiller JT, Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995; 311: 1346.
  • 46
    Han C, Qiao G, Hubbert NL et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst 1996; 88: 14671471.
  • 47
    Carter J, Koutsky L, Hughes J et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181: 19111919.
  • 48
    Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumour-suppressor gene in clinical oncology. J Clin Oncol 1995; 13: 10091022.
  • 49
    Gao H, Wang L-D, Zhou Q, Hong J-Y, Huang T-Y, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54: 43424346.
  • 50
    Shen Z, Xu L, Chen X et al. The genetic events of HPV-immortalized esophageal epithelium cells. Int J Mol Med 2001; 8: 537542.
  • 51
    Syrjänen K. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982; 52: 283292.
  • 52
    Hale M, Liptz T, Paterson A. Association between human papillomavirus and carcinoma of the oesophagus in South African blacks. A histochemical and immunohistochemical study. S Afr Med J 1989; 76: 329330.
  • 53
    Chang F, Syrjänen S, Shen Q, Ji H, Syrjänen K. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer 1990; 45: 2125.
  • 54
    Matos M, Golindano C, Guirola E, Wright H, Capozzolo N, Nishimura M. Esophageal lesions caused by human papillomaviruses (HPV). GEN 1990; 44: 377384.
  • 55
    Cao B, Tian X, Li Y et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005; 26: 12801284.
  • 56
    Chang F, Syrjänen S, Shen Q et al. Detection of HPV DNA in esophageal squamous cell carcinoma from the high incidence area of Linxian, China. Scand J Gastroenterol 2000; 35: 123130.
  • 57
    Chang F, Syrjänen S, Shen Q et al. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res 2000; 20: 39353940.
  • 58
    Chen B, Yin H, Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum Pathol 1994; 25: 920923.
  • 59
    Gao G-F, Roth MJ, Wei W-Q et al. No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006; 119: 13541359.
  • 60
    He D, Tsao S, Bu H. Human papillomavirus infection and esophageal squamous cell carcinoma. Chin J Pathol 1996; 25: 351354.
  • 61
    He D, Zhang D-K, Lam K-Y et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72: 959964.
  • 62
    Lavergne D, de Villiers EM. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80: 681684.
  • 63
    Li T, Lu Z-M, Chen K-N et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22: 929934.
  • 64
    Lu S, Luo F, Li H. Detection of human papillomavirus in esophageal squamous cell carcinoma and adjacent tissue specimens in Linxian. Zhonghua Zhong Liu Za Zhi 1995; 23: 220223.
  • 65
    Peixoto Guimaraes D, Hsin Lu S, Snijders P et al. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 2001; 162: 231235.
  • 66
    Suzuk L, Noffsinger A, Hui Y, Fenoglio-Preiser C. Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer 1996; 78: 704710.
  • 67
    Yao P, Li G, Li J et al. Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12: 13521355.
  • 68
    Koshiol J, Wei WQ, Kreimer AR et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010; 127: 93100.
  • 69
    Dai M, Zhang W, Clifford G et al. Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China. Int J Cancer 2007; 121: 13961398.
  • 70
    Li T, Lu ZM, Guo M et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95: 25712576.
  • 71
    Liu Y, Li X, Jin G et al. HPV detection and FHIT expression in esophageal squamous carcinoma from high incidence area in Cixian County. Chin J Cancer 2003; 22: 492495.
  • 72
    Lu X, Zhang Y, Lin R et al. p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. World J Gastroenterol 2004; 10: 27752778.
  • 73
    Shen ZY, Hu SP, Lu LC et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68: 412416.
  • 74
    Si H, Tsao S, Poon C, Cheung A. Human papillomavirus infection and loss of heterozygosity in esophageal squamous cell carcinoma. Cancer Lett 2004; 213: 231239.
  • 75
    Si HX, Tsao SW, Poon CSP, Wang LD, Wong YC, Cheung AL. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 2003; 103: 496500.
  • 76
    Xu W, Zhang L, Lu Z, Li J, Ke Y, Xu G. Detection of human papillomavirus type 16 E6 mRNA in carcinomas of the upper digestive tract. Chin Med J 2003; 83: 19101914.
  • 77
    Zhou X, Guo M, Quan L et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003; 9: 11701173.
  • 78
    Zhou Y, Pan Y, Zhang S, Shi X, Ning T, Ke Y. Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. Br J Cancer 2007; 97: 218222.
  • 79
    Chang F, Syrjänen S, Shen Q, Wang L, Syrjänen K. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993; 72: 25252530.
  • 80
    Li S, Li Y, Wang L et al. Detection of human papillomavirus in tissues of esophageal carcinomas by polymerase chain reaction. Chin J Exp Clin Virol 2008; 22: 251253.
  • 81
    Lu XM, Monnier-Benoit S, Mo LZ et al. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol 2008; 34: 765770.
  • 82
    Shuyama K, Castillo A, Aguayo F et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007; 96: 15541559.
  • 83
    Xu C, Qian X, Zhou X, Zhao Q, Li Y. Expression HPV 16-E6 and E7 oncoproteins in squamous cell carcinoma tissues of esophageal cancer and non-cancer tissues. Chin J Cancer 2004; 23: 165168.
  • 84
    Chang F, Syrjänen S, Wang L, Shen Q, Syrjänen K. p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. Anticancer Res 1997; 17: 709715.
  • 85
    Li Y, Huang G, Xiao H, Huang Y, Mao T, Deng W. The status of human papillomavirus 16 DNA in the tissues of human esophagus carcinoma. J West Chin Univ Med Sci 1991; 22: 157160.
  • 86
    Lu Z, Chen K, Guo M. Detection of HPV in human oesophageal cancer in high incidence area and its correlation with p53 expression. Zhonghua Zhong Liu Za Zhi 2001; 23: 220223.
  • 87
    Zhu L, Su X, Chen K et al. Detection rate of human papillomavirus-16 in esophageal squamous cell carcinoma from different Chinese populations. Chin J Cancer 2005; 24: 870873.
  • 88
    Qi Z-L, Xu X-J, Zhang B, Shen Z-Y, Huo X. Esophageal carcinoma 109 cell line is found positive in HPV type 18. Dis Esophagus 2007; 20: 362363.
  • 89
    Wang X, Tian X, Liu F et al. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010; 10: 19.
  • 90
    Liu W, Jiang X, Zhang M, Zhang Z. The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. Eur J Gastroenterol Hepatol 2010; 22: 6774.
  • 91
    Goto A, Li C-P, Ota S et al. Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol 2011; 83: 13831390.
  • 92
    Zhang D, Zhang Q, Zhou L et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010; 10: 650658.
  • 93
    Ding G-C, Ren J-L, Chang F-B et al. Human papillomavirus DNA and P16INK4A expression in concurrent esophageal and gastric cardia cancers. World J Gastroenterol 2010; 16: 59015906.
  • 94
    de Villiers E, Lavergne D, Chang F et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 1999; 81: 225228.
  • 95
    Ding G-C, Wang L-D, Li S-H et al. Correlation between human papillomavirus infection and esophageal squamous cell carcinoma and gastric cardia adenocarcinoma in high-incidence area of Henan province. Chin J Cancer Prev Treat 2009; 16: 252255.
  • 96
    Kawaguchi H, Ohno S, Araki K et al. p53 Polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000; 60: 27532755.
  • 97
    Qi Z, Huo X, Xu X et al. Relationship between HPV16/18 E6 and p53, p21WAF1, MDM2, Ki67 and cyclin D1expression in esopha geal squamous cell car cinoma: comparative study by using tissue microarray technology. Exp Oncol 2006; 28: 235240.
  • 98
    Song C-S, Cui J-H, Wu Z-P, Yang G, Tan J-J. Relationship between detection of human papillomavirus genotypes and esophageal squamous cell carcinoma. Chin J Cancer Prev Treat 2009; 16: 329331.
  • 99
    Eslami Far A, Aghakhani A, Hamkar R et al. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis 2007; 39: 5862.
  • 100
    Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. Gastroenterology 2005; 11: 12001203.
  • 101
    Moradi A, De Villiers E, Mokhtari-Azad T et al. Detection of human papillomavirus DNA by PCR in esophageal squamous cell carcinoma from Turkmen Sahra, north-east of Iran. Iran Biomed J 2002; 6: 1923.
  • 102
    Mohseni MSM. Detection of human papilloma virus in esophageal squamous cell carcinoma in Guilan province. J Clin Diagnost Res 2010; 4: 23732377.
  • 103
    Moradi A, Mokhtari-Azad T. Detection of HPV in cancerous and non-cancerous esophageal tissues from Turkmen-Sahra, Iran. Int J Cancer Res 2006; 2: 113118.
  • 104
    Togawa K, Jaskiewicz K, Takahashi H, Meltzer S, Rustgi A. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994; 107: 128136.
  • 105
    Emadian O, Naghshvar F, Rafiei A, Maleki L, Torabizadeh Z, Rezaei Far M. Correlation of human papillomavirus infection with esophageal squamous cell carcinoma. J Babol Univ Med Sci 2011; 13: 5459.
  • 106
    Cooper K, Taylor L, Govind S. Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 1995; 175: 273277.
  • 107
    Matsha T, Donninger H, Erasmus RT, Hendricks D, Stepien A, Parker MI. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 2007; 369: 182190.
  • 108
    Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI. Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002; 55: 587590.
  • 109
    van Rensburg E, Venter E, Simson I. Human papillomavirus DNA in aerodigestive squamous carcinomas demonstrated by means of in situ hybridisation. S Afr Med J 1993; 83: 516518.
  • 110
    Williamson A, Jaskiesicz K, Gunning A. The detection of human papilllomavirus in oesophageal lesions. Anticancer Res 1991; 11: 263265.
  • 111
    Cooper K. p53 mutations in human papillomavirus-associated oesophageal squamous cell carcinoma. Br J Cancer 1995; 72: 1337.
  • 112
    Akutsu N, Shirasawa H, Nakano K et al. Rare association of human papillomavirus DNA with esophageal cancer in Japan. J Infect Dis 1995; 171: 425428.
  • 113
    Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993; 54: 226230.
  • 114
    Hasegawa M, Ohoka I, Yamazaki K et al. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002; 52: 442450.
  • 115
    Hosone M, Ishiwata T, Nomura N, Kawanami O. A molecular pathological study on the localization of the human papillomavirus using nested PCR and in situ hybridization methods in paraffin embedded tissues. Nippon Ika Daigaku Zasshi 1995; 62: 131141.
  • 116
    Khurshid A, Kazuya N, Hanae I, Manabu I. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. J Pak Med Assoc 1998; 48: 138142.
  • 117
    Kuwano H, Sumiyoshi K, Sonoda K et al. Pathogenesis of esophageal squamous cell carcinoma with lymphoid stroma. Hepatogastroenterology 2001; 48: 458461.
  • 118
    Mizobuchi S, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Terada M. Absence of human papillomavirus-16 and -18 DNA and Epstein–Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 1997; 27: 15.
  • 119
    Nakamura T, Ide H, Eguchi R et al. Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma. Surg Today 1995; 25: 591597.
  • 120
    Ono H, Takahashi A, Ogoshi S, Furihata M, Ohtsuki Y. Relationship between H-ras p21 product and p53 protein or high-risk human papillomaviruses in esophageal cancer from Kochi, Japan. Am J Gastroenterol 1994; 89: 646647.
  • 121
    Saegusa M, Hashimura M, Takano Y, Ohbu M, Okayasu I. Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. Mol Pathol 1997; 50: 101104.
  • 122
    Shibagaki I, Tanaka H, Shimada Y et al. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin Cancer Res 1995; 1: 769773.
  • 123
    Sugimachi K, Sumiyoshi K, Nozoe T et al. Carcinogenesis and histogenesis of oesophageal carcinoma. Cancer 1995; 75: 14401445.
  • 124
    Takahashi A, Ogoshi S, Ono H et al. High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Dis Esophagus 1998; 11: 162167.
  • 125
    Toh Y, Kuwano H, Tanaka S et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992; 70: 22342238.
  • 126
    White RE, Mungatana C, Mutuma G et al. Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. Dis Esophagus 2005; 18: 2830.
  • 127
    Agarwal S, Chatterji A, Bhambhani S, Sharma B. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer. Indian J Exp Biol 1998; 36: 559563.
  • 128
    Hussain S, Bharti A, Salam I et al. Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human papillomavirus infection. BMC Cancer 2009; 9: 329.
  • 129
    Katiyar S, Hedau S, Jain N et al. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005; 218: 6979.
  • 130
    Sobti R, Kochar J, Singh K, Bhasin D, Capalash N. Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population. Mol Cell Biochem 2001; 217: 5156.
  • 131
    Lam K-Y, He D, Ma L et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol 1997; 28: 657663.
  • 132
    Loke S, Ma L, Wong M, Srivastava G, Lo I, Bird C. Human papillomavirus in oesophageal squamous cell carcinoma. J Clin Pathol 1990; 43: 909912.
  • 133
    Wang L, Chow K, Wu Y, Li W, Huang M. Detection of Epstein–Barr virus in esophageal squamous cell carcinoma in Taiwan. Am. J Gastroenterol 1999; 94: 28342839.
    Direct Link:
  • 134
    Antonsson A, Nancarrow D, Brown I et al. High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 20802087.
  • 135
    Kulski J, Demeter T, Mutavdzic S, Sterrett G, Mitchell K, Pixley E. Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridisation. Am J Clin Pathol 1990; 94: 566570.
  • 136
    Kulski J, Demeter T, Sterrett GF, Shilkin KB. Human papillomavirus DNA in oesophageal carcinoma. Lancet 1986; 328: 683684.
  • 137
    Benamouzig R, Jullian E, Pompidou A, Rautureau J. Are human papillomaviruses involved in esophageal carcinogenesis? Head Neck Cancer Adv Basic Res 1996; 114: 391395.
  • 138
    Benamouzig R, Pigot F, Quiroga G et al. Human papillomavirus infection in esophageal squamous-cell carcinoma in western countries. Int J Cancer 1992; 50: 549552.
  • 139
    Ashworth M, McDicken I, Southern S, Nash J. Human papillomavirus in squamous cell carcinoma of the oesophagus associated with tylosis. J Clin Pathol 1993; 46: 573575.
  • 140
    Morgan RJ, Perry ACF, Newcomb PV, Hardwick RH, Alderson D. Human papillomavirus and oesophageal squamous cell carcinoma in the UK. Eur J Surg Oncol 1997; 23: 513517.
  • 141
    Kiki I, Gundogdu M, Polat F, Gundogdu C. Detection of human papillomavirus infection in esophageal carcinomas by the histopathological method and polymerase chain reaction technique. Turk J Med Sci 2002; 32: 223230.
  • 142
    Kok TC, Nooter K, Tjong-A-Hung SP, Smits HL, Schegget JT. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Eur J Cancer 1997; 33: 18651868.
  • 143
    Smits HL, Tjong-A-Hung SP, Schegget JT, Nooter K, Kok T. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 1995; 46: 213215.
  • 144
    Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Hölscher AH, Pfister H. Esophageal cancer in Germany is associated with Epstein–Barr-virus but not with papillomaviruses. Med Microbiol Immunol (Berl) 2003; 192: 137140.
  • 145
    de Villiers E, Gunst K, Stein H, Scherübl H. Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences. Int J Cancer 2004; 109: 253258.
  • 146
    Pantelis A, Pantelis D, Ruemmele P et al. p53 codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol Rep 2007; 17: 12431248.
  • 147
    Poljak M, Cerar A. Human papillomavirus type 16 DNA in oesophageal squamous cell carcinoma. Anticancer Res 1993; 13: 21132116.
  • 148
    Poljak M, Cerar A, Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 1998; 29: 266271.
  • 149
    Lambot M, Haot J, Peny M, Fayt I, Noel J. Evaluation of the role of human papillomavirus in oesophageal squamous cell carcinoma in Belgium. Acta Gastroenterol Belg 2000; 63: 154156.
  • 150
    Dreilich M, Bergqvist M, Moberg M et al. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006; 6: 94.
  • 151
    Lewensohn-Fuchs I, Munck-Wikland E, Berke Z et al. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Res 1994; 14: 12811285.
  • 152
    Lyronis I, Baritaki S, Bizakis I, Tsardi M, Spandidos D. Evaluation of the prevalence of human papillomavirus and Epstein–Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 2005; 20: 510.
  • 153
    Fidalgo PO, Cravo ML, Chaves PP, Leitão CN, Mira FC. High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction. Cancer 1995; 76: 15221528.
  • 154
    Bognar G, Imdahl A, György L, Pál O. HPV-infection in esophageal cancer as possible predictive factor after neoadjuvant therapy. Magy Seb 2006; 59: 97104.
  • 155
    Astori G, Merluzzi S, Arzese A et al. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 2001; 64: 914.
  • 156
    Rugge M, Bovo D, Busatto G et al. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev 1997; 6: 171176.
  • 157
    Talamini G, Capelli P, Zamboni G, Mastromauro M, Pasetto M, Castagnini A. Alcohol, smoking and papilomavirus infection as risk factors for esophageal squamous cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 2000; 86: 874878.
  • 158
    Tornesello ML, Monaco R, Nappi O, Buonaguro L, Buonaguro FM. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J Clin Virol 2009; 45: 2833.
  • 159
    Hippeläinen M, Eskelinen M, Lipponen P, Chang F, Syrjänen K. Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res 1993; 13: 677681.
  • 160
    Souto Damin AP, Guedes Frazzon AP, de Carvalho DD et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus 2006; 19: 6468.
  • 161
    Weston AC, Prolla JC. Association between esophageal squamous cell carcinoma and human papillomavirus detected by hybrid capture II assay. Dis Esophagus 2003; 16: 224228.
  • 162
    Acevedo-Nuno E, Gonzalez-Ojeda A, Vazquez-Camacho G, Balderas-Pena Luz Ma A, Moreno-Villa H, Montoya-Fuentes H. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Res 2004; 24: 13191323.
  • 163
    Herrera-Goepfert R, Lizano M, Akiba S, Carrillo-García A, Becker-D'Acosta M. Human papilloma virus and esophageal carcinoma in a Latin-American region. World J Gastroenterol 2009; 15: 31423147.
  • 164
    Castillo A, Aguayo F, Koriyama C et al. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 2006; 12: 61886192.
  • 165
    Mancilia L, Carrascal E, Tamayo O et al. Role of human papillomavirus type 16 in squamous cell carcinoma of upper aerodigestive tracts in Colombian patients. Int J Cancer Res 2011; 7: 222232.
  • 166
    Bahnassy A, Zekri A, Abdallah S, El-Shehaby A, Sherif G. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int 2005; 55: 5362.
  • 167
    Kim W, Song S, Kang J, Park I, Choi H. Detecttion of human papillomavirus DNA from esophageal cancer tissue using polymerase chain reaction. Gastroenterology 1991; 100: A1272.
  • 168
    Koh JS, Lee S-S, Baek HJ, Kim YI. No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Dis Esophagus 2008; 21: 114117.
  • 169
    Woo Y, Yoon H. In situ hybridisation study on human papilomavirus DNA expression in benign and malignant squamous lesions of the esophagus. J Korean Med Sci 1996; 11: 467473.
  • 170
    Baines JE, McGovern RM, Persing D, Gostout BS. Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas. J Virol Methods 2005; 123: 8187.
  • 171
    Kamath AM, Wu TT, Heitmiller R, Daniel R, Shah KV. Investigation of the association of esophageal carcinoma with human papillomaviruses. Dis Esophagus 2000; 13: 122124.
  • 172
    Kiyabu M, Shibata D, Arnheim N, Martin W, Fitzgibbons P. Detection of human papillomavirus in formalin-fixed, invasive squamous cell carcinoma using polymerase chain reaction. Am J Surg Pathol 1989; 13: 221224.
  • 173
    Paz I, Cook N, Odom-Maryon T, Xie Y, Wilczynski S. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997; 79: 595604.
  • 174
    Turner JR, Shen LH, Crum CP, Dean PJ, Odze RD. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 1997; 28: 174178.
  • 175
    Malik SM, Nevin DT, Cohen S, Hunt JL, Palazzo JP. Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma. Int J Surg Pathol 2011; 19: 3134.
  • 176
    Lenhart D, Rifley W, Manalo P, McGregor B. Association of human papillomavirus with esophageal neoplasms. Dis Esophagus 1991; 4: 123128.
  • 177
    Miller BA, Davidson M, Myerson D et al. Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska natives. Int J Cancer 1997; 71: 218222.
  • 178
    Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. Int J Cancer 2002; 102: 271274.
  • 179
    Wang Z, Tang L, Sun G et al. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer 2006; 6: 287.
  • 180
    Bai S, Zhang S, Li B. Primary esophageal adenocarcinoma. Zhonghua Zhong Liu Za Zhi 1989; 11: 383385.
  • 181
    Chang F, Shen Q, Zhou J et al. Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer. Scand J Gastroenterol 1990; 25: 383388.
  • 182
    Mahboubi E, Kmet J, Cook P, Day N, Ghadirian P, Salmasizadeh S. Oesophageal cancer registry studies in the Caspian littoral of Iran: the Caspian cancer registry. Br J Cancer 1973; 28: 197214.
  • 183
    Souto Damin AP, Guedes Frazzon AP, De Carvalho Damin D et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus 2006; 19: 6468.
  • 184
    Group FIS. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 19151927.
  • 185
    Paavonen J, Naud P, Salmerón J et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and pre-cancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2007; 374: 304314.
  • 186
    Mao C, Koutsky L, Ault K et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 2006; 107: 1827.
  • 187
    Garland S. Prevention strategies against human papillomavirus in males. Gynecol Oncol 2010; 117: S2025.
  • 188
    Cui M-C, Li Y, He X, Wang X-L, Wang L-D, Liu H-S. Study of human papillomavirus in biospy tissue specimens of esophageal carcinomas in Linzhou City. Chin J Exp Clin Virol 2011; 25: 3941.
  • 189
    Kahn T, Schwarz E, zur Hausen H. Molecular cloning and characterization of the DNA of a new human papilHBlomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 1986; 37: 6165.